Tumisu/ Pixabay.com

Following a recommendation by the European Medicines Agency (EMA), the European Commission has approved a second vaccine against the novel coronavirus SARS-CoV-2.

©  Pete Linforth/Pixabay.com

Italian Angelini Pharma and Swiss CNS disease specialist Arvelle Therapeutics have entered into a definitive merger agreement.

© NIAID

University of Birmingham researchers have invented a COVID-19 RNA test that reduces testing time from 30 minutes to under five, and delivers accurate results. 

123rf.com/foodandmore

Dear readers,

We wish all visitors to our news page a peaceful and healthy New Year and a successful start to the New Year.  Stay healthy! We will be back with the latest news from 4 January.

Best regards

Your editorial team of European Biotechnology Magazine

© NIAID

Following a rapid FDA approval, the European drug authority EMA has recommended to conditionally  approve BioNTech’s mRNA vaccine BNT162b2 in the EU.

Gerd Altmann/pixabay.com

Only two and a half months after its launch, the EU bioecocomy venture capital fund ECBF has doubled the volume of its first closing.

© Arek Socha /Pixabay.com

Danish Novo Holdings has founded Hemab ApS that is focussed on fighting orphan bleeding disorders by bi-specific antibodies.

Strasbourg-based Transgene appoints Hedi Ben Brahim as Chairman and Chief Executive Officer.

Biotech Austria President-elect Peter Llewellyn-Davies. @ Apeiron Biologics AG

Austria has needed a biotech association for a long time. In just two months, entrepreneurs have launched Biotech Austria.

© CEFIC

Weathered microplastic particles may pose a greater risk than pristine ones, suggests a study of German researchers on mouse cells.